home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Viveve Medical, Inc. - Common Stock (NQ:VIVE)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 18, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viveve Medical, Inc. - Common Stock

< Previous 1 2 3 4 Next >

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 18, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

January 18, 2023

We're starting the day with a breakdown of the biggest pre-market stock movers traders will want to watch on Wednesday morning!

Via InvestorPlace

Nasdaq Edges Higher; Neovasc Shares Jump ↗

January 17, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 17, 2023

Via Benzinga

Viveve Medical Seeks Strategic Alternatives After Failed Stress Urinary Incontinence Trial ↗

January 17, 2023

Via Benzinga

Viveve Announces Completion of Pivotal US PURSUIT Trial for Female Stress Urinary Incontinence with Final 12-month Follow-up Visits Concluded

December 15, 2022

Via ACCESSWIRE

Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary Incontinence

December 01, 2022

Via ACCESSWIRE

Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 17, 2023

Gainers Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

January 17, 2023

Tuesday saw 9 companies set new 52-week lows.

Via Benzinga

Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views ↗

January 17, 2023

U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping over 300 points on Tuesday.

Via Benzinga

Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate Update

November 10, 2022

Via ACCESSWIRE

Viveve Announces Notice of Allowance for Second U.S. Method Patent for Treating Female Stress Urinary Incontinence

October 04, 2022

Via ACCESSWIRE

Why Is Tritium (DCFC) Stock Up 27% Today? ↗

January 17, 2023

Tritium (DCFC) stock is rocketing higher on Tuesday thanks to a couple of pieces of positive news from the EV charging company.

Via InvestorPlace

XPEV Stock Alert: What to Know as Xpeng Slashes Prices ↗

January 17, 2023

Xpeng (XPEV) stock is slipping on Tuesday after the EV maker cut the price of its cars in China to keep up with competitors.

Via InvestorPlace

Why Is Mullen Automotive (MULN) Stock Down 11% Today? ↗

January 17, 2023

Mullen Automotive (MULN) stock is falling on Tuesday as investors prepare for an upcoming shareholder meeting on Thursday.

Via InvestorPlace

Why Is Viveve Medical (VIVE) Stock Down 69% Today? ↗

January 17, 2023

Viveve Medical (VIVE) stock is falling hard on Tuesday after releasing poor results from the company's latest clinical trial.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 17, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

January 17, 2023

We're starting off Tuesday with a look at the biggest pre-market stock movers that traders will want to keep an eye on today!

Via InvestorPlace

Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence

January 17, 2023

Via ACCESSWIRE

Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session ↗

December 23, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 16, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

December 12, 2022

Monday saw 196 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

November 29, 2022

On Tuesday, 89 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

December 02, 2022

On Friday, 72 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

November 17, 2022

OnThursday, 137 stocks made new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

November 16, 2022

On Wednesday, 70 companies set new 52-week lows.

Via Benzinga

InvestorNewsBreaks — Viveve Medical Inc. (NASDAQ: VIVE) Releases Q3 2022 Financial Report, Corporate Update

November 11, 2022

Via Investor Brand Network

Topics Intellectual Property

Stocks That Hit 52-Week Lows On Friday ↗

November 11, 2022

On Friday, 63 stocks hit new 52-week lows.

Via Benzinga

Viveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022

October 27, 2022

Via ACCESSWIRE

Earnings Scheduled For November 10, 2022 ↗

November 10, 2022

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com